GlaxoSmithKline PLC has bowed out of the auction for Pfizer Inc.'s consumer health business – it’s a good move by the UK giant, which recently laid out a strategy that focused on growth in pharmaceuticals.
While a mammoth acquisition in the over-the-counter sector would fit GSK's modus operandi, consumer health units are struggling in the...








